ANALYSIS OF PHENOTYPIC FEATURES AND FGFR2 MUTATIONS IN APERT SYNDROME

被引:1
|
作者
PARK, WJ
THEDA, C
MAESTRI, NE
MEYERS, GA
FRYBURG, JS
DUFRESNE, C
COHEN, MM
JABS, EW
机构
[1] JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205
[2] JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205
[3] JOHNS HOPKINS UNIV,SCH MED,DEPT SURG,BALTIMORE,MD 21205
[4] UNIV VIRGINIA,DEPT PEDIAT,CHARLOTTESVILLE,VA
[5] GEORGETOWN UNIV,DEPT PLAST SURG,WASHINGTON,DC
[6] FAIRFAX HOSP,CTR FACIAL REHABIL,FAIRFAX,VA
[7] DALHOUSIE UNIV,DEPT ORAL & MAXILLOFACIAL SURG,HALIFAX,NS,CANADA
[8] DALHOUSIE UNIV,DEPT PEDIAT,HALIFAX,NS,CANADA
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A phenotypic and genotypic survey was conducted on 36 Apert syndrome patients. In all but one patient, an FGFR2 mutation, either S252W or P253R, was found in exon IIIa (exon U or 7). The frequency was 71% and 26%, for the mutations S252W and P253R, respectively. These mutations occur in the linker region between immunoglobulin-like domains II and Iii, which are involved in activation of the receptor by ligand binding and dimerization. The fact that one patient did not have a mutation in the same exon suggests further genetic heterogeneity in Apert syndrome. The frequencies of occurrence or means for measurements of 29 different clinical features (including severity of craniofacial features, syndactyly of the hands and feet, and multisystem involvement) were determined for all patients and for the two subgroups defined by their mutations. Comparison between the subgroups for the different clinical features was performed and suggested no statistically significant differences, These results are not unexpected, because the two common mutations for Apert syndrome alter FGFR2 at adjacent amino acids that are likely to have similar biological, and therefore phenotypic, consequences.
引用
收藏
页码:321 / 328
页数:8
相关论文
共 50 条
  • [11] Apert syndrome with a second novel mutation in the FGFR2 gene.
    Nezarati, MM
    Steele, L
    Withers, SJ
    Ray, PN
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 381 - 381
  • [12] Brain Phenotypes in Two FGFR2 Mouse Models for Apert Syndrome
    Aldridge, Kristina
    Hill, Cheryl A.
    Austin, Jordan R.
    Percival, Christopher
    Martinez-Abadias, Neus
    Neuberger, Thomas
    Wang, Yingli
    Jabs, Ethylin Wang
    Richtsmeier, Joan T.
    DEVELOPMENTAL DYNAMICS, 2010, 239 (03) : 987 - 997
  • [13] Differential effects of FGFR2 mutation in ophthalmic findings in Apert syndrome
    Khong, Jwu Jin
    Anderson, Peter J.
    Hammerton, Michael
    Roscioli, Tony
    Selva, Dinesh
    David, J. David
    JOURNAL OF CRANIOFACIAL SURGERY, 2007, 18 (01) : 39 - 42
  • [14] Discussion: FGFR2 mutations among Thai children with Crouzon and Apert syndromes
    Scheuerle, A
    JOURNAL OF CRANIOFACIAL SURGERY, 2003, 14 (01) : 105 - 107
  • [15] FGFR1 and FGFR2 Mutations in Pfeiffer Syndrome
    Chokdeemboon, Chayanin
    Mahatumarat, Charan
    Rojvachiranonda, Nond
    Tongkobpetch, Siraprapa
    Suphapeetiporn, Kanya
    Shotelersuk, Vorasuk
    JOURNAL OF CRANIOFACIAL SURGERY, 2013, 24 (01) : 150 - 152
  • [16] Knock-in mouse models for phenotypic comparison of the Apert syndrome Fgfr2 Ser252Trp and Pro253Arg mutations
    Xiao, R
    Huso, D
    Lerner, CP
    Paznekas, WA
    Conover, J
    Yu, K
    Ornitz, DM
    Jabs, EW
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 317 - 317
  • [17] Novel FGFR2 mutation associated with a partial Apert syndrome phenotype.
    Manchester, DK
    Allen, JK
    Handler, M
    Schaefer, FV
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A477 - A477
  • [18] Pfeiffer syndrome is not caused by haploinsufficient mutations of FGFR2
    Johnson, D
    Wilkie, AOM
    JOURNAL OF CRANIOFACIAL GENETICS AND DEVELOPMENTAL BIOLOGY, 2000, 20 (02): : 109 - 111
  • [19] Constitutive receptor activation by Crouzon syndrome mutations in FGFR2 and FGFR2/Neu chimeras.
    Donoghue, DJ
    Galvin, BD
    Hart, KC
    Meyer, AN
    Webster, MK
    MOLECULAR BIOLOGY OF THE CELL, 1996, 7 : 1090 - 1090
  • [20] A deletion of FGFR2 creating a chimeric IIIb/IIIc exon in a child with Apert syndrome
    Fenwick, Aimee L.
    Bowdin, Sarah C.
    Klatt, Regan E. M.
    Wilkie, Andrew O. M.
    BMC MEDICAL GENETICS, 2011, 12